Diagnostic Nuclear Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Diagnostic Nuclear Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diagnostic Nuclear Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diagnostic Nuclear Drug Overall Market Size
2.1 Global Diagnostic Nuclear Drug Market Size: 2022 VS 2030
2.2 Global Diagnostic Nuclear Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diagnostic Nuclear Drug Players in Global Market
3.2 Top Global Diagnostic Nuclear Drug Companies Ranked by Revenue
3.3 Global Diagnostic Nuclear Drug Revenue by Companies
3.4 Top 3 and Top 5 Diagnostic Nuclear Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Diagnostic Nuclear Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diagnostic Nuclear Drug Players in Global Market
3.6.1 List of Global Tier 1 Diagnostic Nuclear Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Diagnostic Nuclear Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diagnostic Nuclear Drug Market Size Markets, 2022 & 2030
4.1.2 Tc-99m
4.1.3 F-18
4.1.4 Other
4.2 By Type - Global Diagnostic Nuclear Drug Revenue & Forecasts
4.2.1 By Type - Global Diagnostic Nuclear Drug Revenue, 2018-2023
4.2.2 By Type - Global Diagnostic Nuclear Drug Revenue, 2024-2030
4.2.3 By Type - Global Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diagnostic Nuclear Drug Market Size, 2022 & 2030
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Other
5.2 By Application - Global Diagnostic Nuclear Drug Revenue & Forecasts
5.2.1 By Application - Global Diagnostic Nuclear Drug Revenue, 2018-2023
5.2.2 By Application - Global Diagnostic Nuclear Drug Revenue, 2024-2030
5.2.3 By Application - Global Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Diagnostic Nuclear Drug Market Size, 2022 & 2030
6.2 By Region - Global Diagnostic Nuclear Drug Revenue & Forecasts
6.2.1 By Region - Global Diagnostic Nuclear Drug Revenue, 2018-2023
6.2.2 By Region - Global Diagnostic Nuclear Drug Revenue, 2024-2030
6.2.3 By Region - Global Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Diagnostic Nuclear Drug Revenue, 2018-2030
6.3.2 US Diagnostic Nuclear Drug Market Size, 2018-2030
6.3.3 Canada Diagnostic Nuclear Drug Market Size, 2018-2030
6.3.4 Mexico Diagnostic Nuclear Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Diagnostic Nuclear Drug Revenue, 2018-2030
6.4.2 Germany Diagnostic Nuclear Drug Market Size, 2018-2030
6.4.3 France Diagnostic Nuclear Drug Market Size, 2018-2030
6.4.4 U.K. Diagnostic Nuclear Drug Market Size, 2018-2030
6.4.5 Italy Diagnostic Nuclear Drug Market Size, 2018-2030
6.4.6 Russia Diagnostic Nuclear Drug Market Size, 2018-2030
6.4.7 Nordic Countries Diagnostic Nuclear Drug Market Size, 2018-2030
6.4.8 Benelux Diagnostic Nuclear Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Diagnostic Nuclear Drug Revenue, 2018-2030
6.5.2 China Diagnostic Nuclear Drug Market Size, 2018-2030
6.5.3 Japan Diagnostic Nuclear Drug Market Size, 2018-2030
6.5.4 South Korea Diagnostic Nuclear Drug Market Size, 2018-2030
6.5.5 Southeast Asia Diagnostic Nuclear Drug Market Size, 2018-2030
6.5.6 India Diagnostic Nuclear Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Diagnostic Nuclear Drug Revenue, 2018-2030
6.6.2 Brazil Diagnostic Nuclear Drug Market Size, 2018-2030
6.6.3 Argentina Diagnostic Nuclear Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diagnostic Nuclear Drug Revenue, 2018-2030
6.7.2 Turkey Diagnostic Nuclear Drug Market Size, 2018-2030
6.7.3 Israel Diagnostic Nuclear Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Diagnostic Nuclear Drug Market Size, 2018-2030
6.7.5 UAE Diagnostic Nuclear Drug Market Size, 2018-2030
7 Diagnostic Nuclear Drug Companies Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Company Summary
7.1.2 Bracco Imaging Business Overview
7.1.3 Bracco Imaging Diagnostic Nuclear Drug Major Product Offerings
7.1.4 Bracco Imaging Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.1.5 Bracco Imaging Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Diagnostic Nuclear Drug Major Product Offerings
7.2.4 Bayer Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Curium Pharmaceuticals
7.3.1 Curium Pharmaceuticals Company Summary
7.3.2 Curium Pharmaceuticals Business Overview
7.3.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Major Product Offerings
7.3.4 Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.3.5 Curium Pharmaceuticals Key News & Latest Developments
7.4 Nordion
7.4.1 Nordion Company Summary
7.4.2 Nordion Business Overview
7.4.3 Nordion Diagnostic Nuclear Drug Major Product Offerings
7.4.4 Nordion Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.4.5 Nordion Key News & Latest Developments
7.5 Triad Isotopes
7.5.1 Triad Isotopes Company Summary
7.5.2 Triad Isotopes Business Overview
7.5.3 Triad Isotopes Diagnostic Nuclear Drug Major Product Offerings
7.5.4 Triad Isotopes Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.5.5 Triad Isotopes Key News & Latest Developments
7.6 Lantheus
7.6.1 Lantheus Company Summary
7.6.2 Lantheus Business Overview
7.6.3 Lantheus Diagnostic Nuclear Drug Major Product Offerings
7.6.4 Lantheus Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.6.5 Lantheus Key News & Latest Developments
7.7 GE Healthcare
7.7.1 GE Healthcare Company Summary
7.7.2 GE Healthcare Business Overview
7.7.3 GE Healthcare Diagnostic Nuclear Drug Major Product Offerings
7.7.4 GE Healthcare Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.7.5 GE Healthcare Key News & Latest Developments
7.8 China Isotope & Radiation
7.8.1 China Isotope & Radiation Company Summary
7.8.2 China Isotope & Radiation Business Overview
7.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Major Product Offerings
7.8.4 China Isotope & Radiation Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.8.5 China Isotope & Radiation Key News & Latest Developments
7.9 Jubilant Pharma
7.9.1 Jubilant Pharma Company Summary
7.9.2 Jubilant Pharma Business Overview
7.9.3 Jubilant Pharma Diagnostic Nuclear Drug Major Product Offerings
7.9.4 Jubilant Pharma Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.9.5 Jubilant Pharma Key News & Latest Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Company Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Diagnostic Nuclear Drug Major Product Offerings
7.10.4 Eli Lilly Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.10.5 Eli Lilly Key News & Latest Developments
7.11 Novartis
7.11.1 Novartis Company Summary
7.11.2 Novartis Business Overview
7.11.3 Novartis Diagnostic Nuclear Drug Major Product Offerings
7.11.4 Novartis Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.11.5 Novartis Key News & Latest Developments
7.12 SIEMENS
7.12.1 SIEMENS Company Summary
7.12.2 SIEMENS Business Overview
7.12.3 SIEMENS Diagnostic Nuclear Drug Major Product Offerings
7.12.4 SIEMENS Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.12.5 SIEMENS Key News & Latest Developments
7.13 Dongcheng
7.13.1 Dongcheng Company Summary
7.13.2 Dongcheng Business Overview
7.13.3 Dongcheng Diagnostic Nuclear Drug Major Product Offerings
7.13.4 Dongcheng Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.13.5 Dongcheng Key News & Latest Developments
7.14 Navidea
7.14.1 Navidea Company Summary
7.14.2 Navidea Business Overview
7.14.3 Navidea Diagnostic Nuclear Drug Major Product Offerings
7.14.4 Navidea Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
7.14.5 Navidea Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Diagnostic Nuclear Drug Market Opportunities & Trends in Global Market
Table 2. Diagnostic Nuclear Drug Market Drivers in Global Market
Table 3. Diagnostic Nuclear Drug Market Restraints in Global Market
Table 4. Key Players of Diagnostic Nuclear Drug in Global Market
Table 5. Top Diagnostic Nuclear Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Diagnostic Nuclear Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Diagnostic Nuclear Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Diagnostic Nuclear Drug Product Type
Table 9. List of Global Tier 1 Diagnostic Nuclear Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diagnostic Nuclear Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Diagnostic Nuclear Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Diagnostic Nuclear Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Diagnostic Nuclear Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Diagnostic Nuclear Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Diagnostic Nuclear Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Diagnostic Nuclear Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Diagnostic Nuclear Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Diagnostic Nuclear Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Diagnostic Nuclear Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Diagnostic Nuclear Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Diagnostic Nuclear Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Diagnostic Nuclear Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Diagnostic Nuclear Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Diagnostic Nuclear Drug Revenue, (US$, Mn), 2024-2030
Table 30. Bracco Imaging Company Summary
Table 31. Bracco Imaging Diagnostic Nuclear Drug Product Offerings
Table 32. Bracco Imaging Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Bracco Imaging Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Diagnostic Nuclear Drug Product Offerings
Table 36. Bayer Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Curium Pharmaceuticals Company Summary
Table 39. Curium Pharmaceuticals Diagnostic Nuclear Drug Product Offerings
Table 40. Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Curium Pharmaceuticals Key News & Latest Developments
Table 42. Nordion Company Summary
Table 43. Nordion Diagnostic Nuclear Drug Product Offerings
Table 44. Nordion Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Nordion Key News & Latest Developments
Table 46. Triad Isotopes Company Summary
Table 47. Triad Isotopes Diagnostic Nuclear Drug Product Offerings
Table 48. Triad Isotopes Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Triad Isotopes Key News & Latest Developments
Table 50. Lantheus Company Summary
Table 51. Lantheus Diagnostic Nuclear Drug Product Offerings
Table 52. Lantheus Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Lantheus Key News & Latest Developments
Table 54. GE Healthcare Company Summary
Table 55. GE Healthcare Diagnostic Nuclear Drug Product Offerings
Table 56. GE Healthcare Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 57. GE Healthcare Key News & Latest Developments
Table 58. China Isotope & Radiation Company Summary
Table 59. China Isotope & Radiation Diagnostic Nuclear Drug Product Offerings
Table 60. China Isotope & Radiation Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 61. China Isotope & Radiation Key News & Latest Developments
Table 62. Jubilant Pharma Company Summary
Table 63. Jubilant Pharma Diagnostic Nuclear Drug Product Offerings
Table 64. Jubilant Pharma Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Jubilant Pharma Key News & Latest Developments
Table 66. Eli Lilly Company Summary
Table 67. Eli Lilly Diagnostic Nuclear Drug Product Offerings
Table 68. Eli Lilly Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Eli Lilly Key News & Latest Developments
Table 70. Novartis Company Summary
Table 71. Novartis Diagnostic Nuclear Drug Product Offerings
Table 72. Novartis Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Novartis Key News & Latest Developments
Table 74. SIEMENS Company Summary
Table 75. SIEMENS Diagnostic Nuclear Drug Product Offerings
Table 76. SIEMENS Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 77. SIEMENS Key News & Latest Developments
Table 78. Dongcheng Company Summary
Table 79. Dongcheng Diagnostic Nuclear Drug Product Offerings
Table 80. Dongcheng Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 81. Dongcheng Key News & Latest Developments
Table 82. Navidea Company Summary
Table 83. Navidea Diagnostic Nuclear Drug Product Offerings
Table 84. Navidea Diagnostic Nuclear Drug Revenue (US$, Mn) & (2018-2023)
Table 85. Navidea Key News & Latest Developments
List of Figures
Figure 1. Diagnostic Nuclear Drug Segment by Type in 2022
Figure 2. Diagnostic Nuclear Drug Segment by Application in 2022
Figure 3. Global Diagnostic Nuclear Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diagnostic Nuclear Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Diagnostic Nuclear Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diagnostic Nuclear Drug Revenue in 2022
Figure 8. By Type - Global Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Diagnostic Nuclear Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Diagnostic Nuclear Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
Figure 16. US Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
Figure 20. Germany Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
Figure 28. China Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Diagnostic Nuclear Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Diagnostic Nuclear Drug Revenue, (US$, Mn), 2018-2030
Figure 41. Bracco Imaging Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Nordion Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Triad Isotopes Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Lantheus Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GE Healthcare Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. China Isotope & Radiation Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Jubilant Pharma Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eli Lilly Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Novartis Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. SIEMENS Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Dongcheng Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Navidea Diagnostic Nuclear Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
